Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,080 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stimwave Technologies Incorporated | $402.00 | 17 | $0 (2020) |
| Flexion Therapeutics, Inc. | $118.46 | 8 | $0 (2019) |
| Bioventus LLC | $114.51 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $104.23 | 1 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $68.36 | 5 | $0 (2020) |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | $54.59 | 4 | $0 (2020) |
| DJO, LLC | $33.37 | 1 | $0 (2019) |
| DePuy Synthes Sales Inc. | $33.04 | 2 | $0 (2019) |
| Orthogenrx Inc. | $31.17 | 2 | $0 (2019) |
| ASSERTIO THERAPEUTICS, Inc. | $28.31 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $87.52 | 6 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($41.80) |
| 2019 | $602.86 | 30 | Stimwave Technologies Incorporated ($368.16) |
| 2018 | $156.85 | 10 | Flexion Therapeutics, Inc. ($61.96) |
| 2017 | $232.29 | 4 | Bioventus LLC ($114.51) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2020 | Stimwave Technologies Incorporated | StimQ Peripheral Nerve StimulatorSystem (Device), SCS FreedonSpinal Cord Stimulator | Food and Beverage | Cash or cash equivalent | $14.31 | General |
| Category: Neurostimulation | ||||||
| 02/19/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Chronic Pain | ||||||
| 02/12/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: Opioid Analgesic | ||||||
| 01/22/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Chronic Pain | ||||||
| 01/16/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BUNAVAIL (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Addiction Therapy | ||||||
| 01/08/2020 | Stimwave Technologies Incorporated | StimQ Peripheral Nerve StimulatorSystem (Device), SCS FreedonSpinal Cord Stimulator | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Neurostimulation | ||||||
| 12/18/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| 12/17/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| 12/04/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.12 | General |
| Category: Opioid Analgesic | ||||||
| 12/02/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| 11/27/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $11.73 | General |
| 11/25/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| 11/13/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| 11/08/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| 10/30/2019 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Addiction Therapy | ||||||
| 10/17/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $11.84 | General |
| 10/14/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| 10/14/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: Opioid Analgesic | ||||||
| 10/10/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| 10/02/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $11.73 | General |
| 09/30/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| 09/23/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $24.81 | General |
| 09/17/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $29.10 | General |
| 08/09/2019 | DJO, LLC | — | Food and Beverage | In-kind items and services | $33.37 | General |
| 08/06/2019 | Stimwave Technologies Incorporated | — | Food and Beverage | Cash or cash equivalent | $135.26 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 512 | 554 | $165,492 | $32,787 |
| 2022 | 6 | 400 | 434 | $136,232 | $29,123 |
| 2021 | 4 | 384 | 395 | $61,606 | $28,451 |
| 2020 | 10 | 401 | 1,215 | $168,989 | $42,476 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 202 | $80,800 | $13,283 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 133 | $53,200 | $12,267 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $21,494 | $4,210 | 19.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 49 | 49 | $6,664 | $1,696 | 25.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 31 | 62 | $2,123 | $1,006 | 47.4% |
| 87430 | Detection test by immunoassay technique for streptococcus, group a (strep) | Office | 2023 | 12 | 12 | $456.00 | $181.17 | 39.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 42 | 42 | $756.00 | $143.22 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 175 | $65,320 | $12,155 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 120 | $45,800 | $11,792 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $20,200 | $3,434 | 17.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 22 | 22 | $2,992 | $906.18 | 30.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 24 | 48 | $1,632 | $782.10 | 47.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 16 | $288.00 | $55.01 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 173 | 181 | $25,340 | $11,867 | 46.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 116 | $23,400 | $11,401 | 48.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 61 | 61 | $12,200 | $5,056 | 41.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 36 | 37 | $666.00 | $128.76 | 19.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 151 | 231 | $41,630 | $13,731 | 33.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 158 | $39,915 | $10,844 | 27.2% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2020 | 12 | 640 | $32,000 | $9,471 | 29.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 48 | 48 | $10,555 | $3,461 | 32.8% |
| 77002 | Fluoroscopic guidance for insertion of needle | Office | 2020 | 16 | 28 | $24,607 | $2,457 | 10.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 16 | 29 | $10,459 | $1,681 | 16.1% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 11 | 12 | $5,167 | $689.26 | 13.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 13 | 18 | $1,800 | $78.88 | 4.4% |
About Dr. Krishna Konakondla, MD
Dr. Krishna Konakondla, MD is a Sports Medicine healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1457761223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krishna Konakondla, MD has received a total of $1,080 in payments from pharmaceutical and medical device companies, with $87.52 received in 2020. These payments were reported across 50 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,080).
As a Medicare-enrolled provider, Konakondla has provided services to 1,697 Medicare beneficiaries, totaling 2,598 services with total Medicare billing of $132,838. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Cherry Hill, NJ
- Active Since 05/02/2014
- Last Updated 10/01/2024
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1457761223
Products in Payments
- Zilretta (Drug) $118.46
- Exogen (Device) $114.51
- COSENTYX (Biological) $104.23
- XTAMPZA (Drug) $68.36
- StimQ Peripheral Nerve StimulatorSystem (Device) $33.84
- GenVisc 850 (Device) $31.17
- BELBUCA (Drug) $28.31
- Gralise (Drug) $28.31
- GalaFLEX (Device) $22.81
- ORTHOVISC (Device) $18.23
- MONOVISC (Device) $14.81
- FIRMAGON (Drug) $14.73
- Amitiza (Drug) $13.65
- LORZONE (Drug) $13.55
- BUNAVAIL (Drug) $13.49
- BOTOX THERAPEUTIC (Biological) $13.41
- SYNCHROMED (Device) $13.33
- BUNAVAIL 2.1 mg 30-count box (Drug) $12.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Cherry Hill
Christopher Chong, M.d, M.D
Sports Medicine — Payments: $4,434
Teresa Coyle, Do, DO
Sports Medicine — Payments: $267.59
Vincent Marchese, Do, DO
Sports Medicine — Payments: $132.83
Andrew O'neill
Sports Medicine — Payments: $61.51
Craig Kimmel, Md, MD
Sports Medicine — Payments: $27.04